HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling
© 2024 The Authors..
Despite low or undetectable plasma viral load, people living with HIV-2 (PLWH2) typically progress toward AIDS. The driving forces behind HIV-2 disease progression and the role of viremia are still not known, but low-level replication in tissues is believed to play a role. To investigate the impact of viremic and aviremic HIV-2 infection on target and bystander cell pathology, we used data-independent acquisition mass spectrometry to determine plasma signatures of tissue and cell type engagement. Proteins derived from target and bystander cells in multiple tissues, such as the gastrointestinal tract and brain, were detected at elevated levels in plasma of PLWH2, compared with HIV negative controls. Moreover, viremic HIV-2 infection appeared to induce enhanced release of proteins from a broader range of tissues compared to aviremic HIV-2 infection. This study expands the knowledge on the link between plasma proteome remodeling and the pathological cell engagement in tissues during HIV-2 infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
iScience - 27(2024), 4 vom: 19. März, Seite 109344 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Johansson, Emil [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 20.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.isci.2024.109344 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36990463X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36990463X | ||
| 003 | DE-627 | ||
| 005 | 20240320235007.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240319s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.isci.2024.109344 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM36990463X | ||
| 035 | |a (NLM)38500818 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Johansson, Emil |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. | ||
| 520 | |a Despite low or undetectable plasma viral load, people living with HIV-2 (PLWH2) typically progress toward AIDS. The driving forces behind HIV-2 disease progression and the role of viremia are still not known, but low-level replication in tissues is believed to play a role. To investigate the impact of viremic and aviremic HIV-2 infection on target and bystander cell pathology, we used data-independent acquisition mass spectrometry to determine plasma signatures of tissue and cell type engagement. Proteins derived from target and bystander cells in multiple tissues, such as the gastrointestinal tract and brain, were detected at elevated levels in plasma of PLWH2, compared with HIV negative controls. Moreover, viremic HIV-2 infection appeared to induce enhanced release of proteins from a broader range of tissues compared to aviremic HIV-2 infection. This study expands the knowledge on the link between plasma proteome remodeling and the pathological cell engagement in tissues during HIV-2 infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Disease | |
| 650 | 4 | |a Human specimen | |
| 650 | 4 | |a Proteomics | |
| 650 | 4 | |a Virology | |
| 700 | 1 | |a Nazziwa, Jamirah |e verfasserin |4 aut | |
| 700 | 1 | |a Freyhult, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, Mun-Gwan |e verfasserin |4 aut | |
| 700 | 1 | |a Lindman, Jacob |e verfasserin |4 aut | |
| 700 | 1 | |a Neptin, Malin |e verfasserin |4 aut | |
| 700 | 1 | |a Karlson, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Rezeli, Melinda |e verfasserin |4 aut | |
| 700 | 1 | |a Biague, Antonio J |e verfasserin |4 aut | |
| 700 | 1 | |a Medstrand, Patrik |e verfasserin |4 aut | |
| 700 | 1 | |a Månsson, Fredrik |e verfasserin |4 aut | |
| 700 | 1 | |a Norrgren, Hans |e verfasserin |4 aut | |
| 700 | 1 | |a Esbjörnsson, Joakim |e verfasserin |4 aut | |
| 700 | 1 | |a Jansson, Marianne |e verfasserin |4 aut | |
| 700 | 0 | |a SWEGUB CORE group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t iScience |d 2018 |g 27(2024), 4 vom: 19. März, Seite 109344 |w (DE-627)NLM285332627 |x 2589-0042 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2024 |g number:4 |g day:19 |g month:03 |g pages:109344 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.isci.2024.109344 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2024 |e 4 |b 19 |c 03 |h 109344 | ||